ClinicalTrials.Veeva

Menu

Neonatal Hypotonia Associated With in Utero Exposure to Antidepressant

C

Caen University Hospital

Status

Unknown

Conditions

Neonatal Hypotonia
Pregnancy Related
Antidepressant Drug Adverse Reaction

Treatments

Drug: Antidepressant

Study type

Observational

Funder types

Other

Identifiers

NCT04830241
HYPOTONIA

Details and patient eligibility

About

To better characterize the neonatal hypotonia associated with in utero exposure to antidepressants, so far limited to clinical cases, we will perform an observational retrospective pharmacovigilance study, using two databases. First, disproportionality analysis in Vigibase®, the World Health Organization global database, will be perform between antidepressant drugs and neonatal hypotonia . Second, narratives from the French National Pharmacovigilance Database will be extracted.

Enrollment

10,000 estimated patients

Sex

All

Ages

1 to 30 days old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • neonatal hypotonia newborns cases associated with in utero exposure to antidepressant drugs

Exclusion criteria

  • Reports with maternal suicide, congenital malformation and hypotonia occurring only during breastfeeding

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems